alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 113
Editorial Note: Nomenclature changes to part 113 appear at 79 FR 55969, Sept. 18, 2014.

§ 113.35 Detection of viricidal activity. The test for detection of viricidal activity provided in this section shall be conducted when such a test is prescribed in an applicable standard requirement or in the filed Outline of Production for each inactivated liquid biological product used as diluent for a desiccated live virus vaccine in a combination package. ( a ) Bulk or final container samples of completed product from each serial shall be tested.
( b ) The product shall be tested with each virus fraction for which it is to be used as a diluent. If the vaccine to be rehydrated contains more than one virus fraction, the test shall be conducted with each fraction after neutralization of the other fraction(s), and/or dilution of the vaccine beyond the titer range of the other fraction(s), or the test shall be conducted using representative single-fraction desiccated vaccines which are prepared by the licensee and which are licensed. *Provided,* That the Administrator may authorize licensees to prepare and use unlicensed single-fraction vaccines for this purpose.
( c ) Test procedure: ( 1 ) Rehydrate at least two vials of the vaccine with the liquid product under test according to label recommendations and pool the contents.
( 2 ) Rehydrate at least two vials of the vaccine with the same volume of sterile purified water and pool the contents.
( 3 ) Neutralize to remove other fractions, if necessary.
( 4 ) Hold the two pools of vaccine at room temperature (20 °to 25 °C) for 2 hours. The holding period shall begin when rehydration is completed.
( 5 ) Titrate the virus(es) in each pool of vaccine as provided in the filed Outline of Production or an applicable standard requirement.
( 6 ) Compare respective titers.
( d ) If the titer of the vaccine virus(es) rehydrated with the product under test is more than 0.7 log10 below the titer of the vaccine virus(es) rehydrated with sterile purified water, the product is unsatisfactory for use as diluent.
( e ) If the product is unsatisfactory in the first test, one retest to rule out faulty techniques may be conducted using four vials of the vaccine for each pool and the acceptability of the product judged by the results of the second test.
( f ) Liquid products found to be unsatisfactory for use as diluent by this test are not prohibited from release as separate licensed products if labeled as prescribed in § 112.7(g).
[44 FR 25412, May 1, 1979, as amended at 56 FR 66784, Dec. 26, 1991; 64 FR 43044, Aug. 9, 1999]
## Breadcrumb

-  Home 
-  Employers & Practitioners 
-  Pending Proposed Rules 

This page has not been translated. Please go to PBGC.gov's Spanish home page for more information available in Spanish.

Esta página no ha sido traducida. Por favor vaya a la página principal del sitio de español de PBGC para ver información disponible en español.

# Pending Proposed Rules
### §5413. Abolishment

Effective 90 days after the transfer date, the Office of Thrift Supervision and the position of Director of the Office of Thrift Supervision are abolished.

(Pub. L. 111–203, title III, §313, July 21, 2010, 124 Stat. 1523.)

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date

Section effective 1 day after July 21, 2010, except as otherwise provided, see section 4 of Pub. L. 111–203, set out as a note under section 5301 of this title.
### SUBCHAPTER IV—ADVANCEMENT OF CYBERSECURITY TECHNICAL STANDARDS
# C_2007095EN.01004801.xml

| 28.4.2007 | EN | Official Journal of the European Union | C 95/48 |
| --- | --- | --- | --- |

28.4.2007

EN

Official Journal of the European Union

C 95/48

---

Action brought on 23 February 2007 — BYK-Chemie v OHIM — (Substance for Success)

(Case T-58/07)

(2007/C 95/96)

Language of the case: German

Parties

Applicant: BYK-Chemie (Wesel, Germany) (represented by: J. Kroher and A. Hettenkofer, lawyers)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Form of order sought

| — | Annul the decision of the Fourth Board of Appeal of the defendant of 9 January 2007 in Case R0816/2006-04; |
| --- | --- |

—

Annul the decision of the Fourth Board of Appeal of the defendant of 9 January 2007 in Case R0816/2006-04;

| — | order the defendant to pay the costs. |
| --- | --- |

—

order the defendant to pay the costs.

Pleas in law and main arguments

Community trade mark concerned: The word mark ‘Substance for success ’for goods and services in Classes 1, 40-42 (Application No 3 660 552).

Community trade mark concerned:

Decision of the Examiner: Rejection of the application.

Decision of the Examiner:

Decision of the Board of Appeal: Dismissal of the appeal.

Decision of the Board of Appeal:

Pleas in law: Breach of Article 7(1)(b) and (c) of Council Regulation No 40/94 (1) as the registered trade mark is neither devoid of the necessary distinctive character nor is to be reserved for use in trade.

Pleas in law:

1

---

(1)  Council Regulation (EC) No 40/94 of 20 December 1993 on the Community trade mark (OJ 1994 L 11, p. 1).

1

---
### SUBCHAPTER II—NEW INITIATIVES TO PROMOTE ECONOMIC RESILIENCY FOR MINORITY BUSINESSES
| Subsidiaries of the Company | Exhibit 8.1 |
|-----------------------------|-------------|

| Subsidiary                                                                                   | Jurisdiction of Incorporation | Principal Activity                         |
|----------------------------------------------------------------------------------------------|-------------------------------|--------------------------------------------|
|                                                                                         |                          |                                       |
| BBVA Francés Asset Management S.A. Sociedad Gerente de Fondos Comunes de Inversión | Republic of Argentina         | Mutual funds                               |
| BBVA Francés Valores S.A.                                                               | Republic of Argentina         | Stock exchange brokerage                   |
| Consolidar AFJP S.A. (undergoing liquidation proceedings)                                    | Republic of Argentina         | Pension and Retirement Fund Administrators |
| PSA Finance Argentina Compañía Financiera S.A.                                     | Republic of Argentina         | Financial Institution                      |

----
§ 117.4 Test animals. ( a ) All test animals shall be examined for clinical signs of illness, injury, or abnormal behavior prior to the start of a test and throughout the observation period specified in the test protocol.
( b ) All animals used for test purposes shall be identified either collectively or individually in a manner conducive to an accurate interpretation of the results of the test.
( c ) No test animals shall be given a biological product during the preconditioning period which would affect its eligibility according to the test requirements. No treatment, with a biological product or otherwise, shall be administered to a test animal during a test period which could interfere with a true evaluation of the biological product being tested.
( d ) During the course of a test, animals that are injured or show clinical signs of illness or unfavorable reactions that are not due to the test may be removed from the test and treated or humanely destroyed. If sufficient animals do not remain for the test to be evaluated, the test shall be declared inconclusive and may be repeated.
( e ) Test animals that show clinical signs of illness that are due to the test may be treated or humanely destroyed if the illness has progressed to a point (defined in the filed Outline of Production) when death is certain to occur without therapeutic intervention. When interpreting the results of the test, the animals that were treated or humanely destroyed because of illness due to the test and the animals that have died from illness due to the test prior to being humanely destroyed shall be combined into a common statistic of mortality due to the test.
[38 FR 15499, June 13, 1973, as amended at 60 FR 43356, Aug. 21, 1995]
```

[Federal Register Volume 77, Number 123 (Tuesday, June 26, 2012)]
[Notices]
[Page 38126]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-15600]

-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 7934]

Foreign Affairs Policy Board Meeting Notice; Closed Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act, 5 U.S.C. App Sec.  10(a)(2), the Department of State 
announces a meeting of the Foreign Affairs Policy Board to take place 
on July 19, 2012, at the Department of State, Washington, DC.
    The Foreign Affairs Policy Board reviews and assesses: (1) Global 
threats and opportunities; (2) trends that implicate core national 
security interests; (3) tools and capacities of the civilian foreign 
affairs agencies; and (4) priorities and strategic frameworks for U.S. 
foreign policy. Pursuant to section 10(d) of the Federal Advisory 
Committee Act, 5 U.S.C. App Sec.  10(d), and 5 U.S.C. 552b(c)(1), it 
has been determined that this meeting will be closed to the public as 
the Board will be reviewing and discussing matters properly classified 
in accordance with Executive Order 13526.
    For more information, contact Samantha Raddatz at (202) 647-2372.

    Dated: June 15, 2012.
Dan Kurtz-Phelan,
Designated Federal Officer.
[FR Doc. 2012-15600 Filed 6-25-12; 8:45 am]
BILLING CODE 4710-10-P
```
-  Home 
-  Hazmat 

# In This Section

                      -  Hazardous Materials Standards & Rulemaking Overview 
                      -  International Program Overview 
                      -  PHMSA's Online CFR (oCFR) 
                      -  Rulemakings                          -  Overview 
                        -  Recently Published Rulemakings 
                        -  Archived Hazardous Materials Rulemakings (pre-1995) 
                      -  Petitions for Rulemaking 
                      -  Interpretations 
                      -  Regulations 
                      -  Preemption Determinations                          -  Overview 
                        -  Inconsistency Rulings 
                      -  Notices and Advisory Bulletins 
                      -  Lithium Battery Air Safety Advisory Committee 
                      -  Hazardous Materials Information Center 

## Related Documents

                  -                                          PD-23RF Initial Decision                   
                  -                                          PD-23RF Decision                   

# PD-23(RF): Morrisville, PA requirements for transporting "dangerous waste," including routing restrictions and manifest requirement
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Health Resources and Services Administration

# AGENCY:

Health Resources and Services Administration, HHS.

# ACTION:

Notice; correction.

# SUMMARY:

                        The Health Resources and Services Administration published a notice in the                         **Federal Register**                         of February 9, 2011 (76 FR 7223-7224) announcing an Advisory Committee on Organ Transplantation meeting on March 8, 2011. The type of meeting, time and place have been changed.                    

## Correction

                        In the                         **Federal Register**                         of February 9, 2011, in FR Doc. 2011-2839, on page 7223, 2nd column, under the heading Department of Health and Human Services, Health Resources and Services Administration, Advisory Committee on Organ Transplantation; Notice of Meeting, change the Times and Place to read:                    

                        The meeting will be an Audio Conference Call on March 8, 2011, from 12 noon to 4 p.m. EST. To access the conference call, call the USA Toll Free Number 888-469-1090 and enter the Passcode 2741198. The conference call leader is Patricia A. Stroup. Participants should call no later than 11:45 a.m. EST in order for logistics to be set up. Participants are asked to register for the conference call by contacting Brittany Carey, HRM/Professional and Scientific Associates (PSA), the logistical support contractor for the meeting, at (703) 889-9033 or                         *b_carey@team-psa.com.*                         The registration deadline is March 7, 2011. The Department will try to accommodate those wishing to participate in the call.                    

                        The next face-to-face ACOT meeting is planned for August 2011. Details regarding an August meeting will be published in a subsequent                         **Federal Register**                         notice.                    

Reva Harris,

Acting Director, Division of Policy and Information Coordination.

[FR Doc. 2011-4755 Filed 3-2-11; 8:45 am]

BILLING CODE 4165-15-P
**EXHIBIT 32.1**
 
 
 **CERTIFICATION PURSUANT TO** **18 U.S.C. SECTION 1350** **AS ADOPTED PURSUANT TO** **SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**
   In connection with the Amendment No. 1 to Annual Report of Wits Basin Precious Minerals Inc. (formerly known as Active IQ Technologies, Inc.) (the Company) on Form 10-K for the year ending December 31, 2002, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, H. Vance White the Chief Executive Officer of the Company, hereby certifies, pursuant to and for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:
   (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
   ****Date: January 14, 2005
By:
/s/ H. Vance WhiteH. Vance WhiteChief Executive Officer
#### § 354.245 Vermin.

Every practicable precaution shall be taken to exclude flies, rats, mice, and other vermin from the official plant. Dogs, cats, and other pets shall be excluded from rooms where edible products are processed, handled, or stored.
**EXHIBIT 23**

**CONSENT OFINDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to theincorporation by reference in the Registration Statements (Forms S-3No. 333-112311, No. 333-38167, No. 333-82685,No. 333-92577, No. 333-36790 and No. 333-51914)and in the related prospectuses, and to the incorporation by reference in theRegistration Statements (Forms S-8 Nos. 333-11299, No. 333-35287,No. 333-85575, 333-59158, No. 333-34320,No. 333-52804, No. 333-59160, No. 333-123452and No. 333-129269) pertaining to the 1993 Stock Plan, the 1996Nonemployee Directors Stock Option Plan, the 1998 Stock Incentive Plan, theGMS/Affymetrix 1998 Stock Plan, the Affymetrix/Neomorphic, Inc. 1998 StockOption Plan, the Amended and Restated 2000 Equity Incentive Plan ofAffymetrix, Inc. and the ParAllele BioScience, Inc. 2001 Stock OptionPlan of Affymetrix, Inc. of our report dated March 2, 2006, (exceptfor Notes 3 and 20, as to which the date is August 23, 2006), with respectto the consolidated financial statements and schedule of Affymetrix, Inc.,and our report dated March 2, 2006, with respect to Affymetrix, Inc.management’s assessment of the effectiveness of internal control over financialreporting, and the effectiveness of internal control over financial reportingof Affymetrix, Inc., included in this Annual Report (Form 10-K/A)for the year ended December 31, 2005.

/s/ ERNST & YOUNG LLP

Palo Alto, CaliforniaJuly 25, 2007

 

----
June 25, 2015

Mr. Gregory Glassman

15 Massabesic Drive Auburn, NH 03032

Dear Mr. Glassman:

This letter is to inform you that we are unable to process your request for an exemption from Title 14, Code of Federal Regulations (14 CFR) . It explains why we can not process your request and what you should do in the next 30 days.

Why We Can Not Process Your Request

We entered your June 12, exemption request into the public docket (No. FAA-2015-2249), but we are unable to process your request any further. The information you sent does not comply with the requirements of § 11.81 (copy enclosed). For us to consider the request any further, you must send us all of the following:

 The specific section or sections of 14 CFR from which you seek relief, the extent of the relief you seek, and the reason you seek relief.

 The reasons why granting the request would be in the public interest; that is, how it would benefit the public as a whole.

 The reasons why the exemption would not adversely affect safety or how the exemption would provide a level of safety at least equal to that provided by the rule from which you seek an exemption.

 Any additional information, views, or arguments available to support your request.2

What You Should Do

If you want us to process your request any further, you must send the information described earlier to reach us within 30 days. Please note that § 11.63(d) requires you to send your petition for exemption at least 120 days before the proposed effective date of the exemption.

If We Do Not Hear From You

If we do not hear from you within 30 days, we will close the docket without notifying you further. If you have any questions or require additional time, you may call (202) 267-9677.

Sincerely,

/s/

Brenda Robeson Program Analyst, Airmen and Airspace Rules Division

Enclosure
**Exhibit 32.1.1.1**

 

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED**

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Annual Report of Foamex International Inc. on Form 10-K/A for the period ended December 30, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John G. Johnson, Jr., Chief Executive Officer of Foamex International Inc., certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|----|-----------------------------------------------------------------------------------------------------------------------|

 

| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Foamex International Inc. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

/s/ John G. Johnson, Jr.

John G. Johnson, Jr.

Chief Executive Officer

April 17, 2008
§ 117.6 Removal of animals. Production animals or ex-test animals which are no longer useful at the licensed establishment may be removed from the premises of the licensed establishment; provided, such removal is accomplished in a manner as shall preclude the dissemination of disease and in accordance with the following conditions: ( a ) Meat-producing animals which received a biological product containing inactivated microorganisms and adjuvants within 21 days shall not be removed; or
( b ) Animals which received virulent microorganisms within 30 days shall not be removed; or
( c ) Only animals that are in a healthy condition as determined by a veterinarian shall be removed, except as provided in paragraph (d) of this section.
( d ) Other animals that are injured or otherwise unhealthy, except when affected with a communicable disease, may be removed for immediate slaughter to an abattoir operated in accordance with the Federal Meat Inspection Act of March 4, 1907, 34 Stat. 1260, as amended by the Wholesome Meat Act of 1967, 81 Stat. 585 (21 U.S.C. sec. 601 *et seq.*): *Provided,* That such animals shall be properly marked for identification and the inspector in charge of slaughter operations is given due notice in advance.
( e ) All animals on the premises shall be disposed of in accordance with the provisions of the regulations in this part and where specific provision is not made therefor shall be disposed of as required by the Administrator.
[38 FR 15499, June 13, 1973, as amended at 56 FR 66784, Dec. 26, 1991]